Asset Details
Do you wish to reserve the book?
Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Do you wish to request the book?
Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
2020
Overview
Monoclonal Gammopathy of Undetermined Significance (MGUS) is considered to be a benign precursor condition that may progress to a lymphoproliferative disease or multiple myeloma. Most patients do not progress to an overt condition, but nevertheless, MGUS is associated with a shortened life expectancy and, in a minority of cases, a number of co-morbid conditions that include an increased fracture risk, renal impairment, peripheral neuropathy, secondary immunodeficiency, and cardiovascular disease. This review aims to consolidate current evidence for the significance of these co-morbidities before considering how best to approach these symptoms and signs, which are often encountered in primary care or within a number of specialties in secondary care.
Publisher
MDPI AG,MDPI
Subject
